Peer AI raised $12.1 million to transform the regulatory documentation bottleneck that adds an average 435 days to drug approval timelines, with specialized AI agents reducing document drafting time by up to 94% while maintaining compliance oversight.

The Series A round led by Flare Capital Partners and SignalFire addresses a critical infrastructure gap in pharmaceutical development, where manual regulatory documentation processes require over 200,000 pages across 1,500+ unique documents per drug approval—contributing to a 75% FDA submission rejection rate due to quality issues.